Early intervention with biological therapy in Crohn´s disease - how early is early?
Joana RevésAndré MascarenhasMaria José TemidoBárbara MorãoCatarina Neto NascimentoAna Rita FrancoRaquel R MendesCarolina PalmelaCristina ChagasPedro Narra FigueiredoLuísa GlóriaFrancisco PortelaJoanna TorresPublished in: Journal of Crohn's & colitis (2023)
Starting anti-TNF therapy within the first 24 months after diagnosis was associated with a low rate of CD-related complications and high rates of clinical and endoscopic remission, although we found no differences with earlier initiation within this window of opportunity.